Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg.
⦁ For patients taking this medicine whose blood glucose is not adequately controlled with metformin alone or in combination with other drugs such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose).
⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin.
When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions).
This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin.
If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose.
Special populations
Patients with renal impairment
No dosage adjustment is necessary in patients with mild renal impairment.
Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other symptoms that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, given as 500 mg twice daily.
Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1).
If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Patients in Whom This Medicine Is Contraindicated, item 2).
Elderly patients
In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
Improvement of glycemic control in adults with type 2 diabetes mellitus
Blood sugar control issues
type 2 diabetes
cardiovascular disease
View approved original textHide original text
This medication assists adult patients with type 2 diabetes in effectively improving blood sugar control while following dietary and exercise regimens. In particular, it can help manage the risk of cardiovascular events for those whose blood sugar is not adequately controlled, especially in patients with cardiovascular disease, when used cautiously under a physician's guidance. Therefore, this medication is used to enhance blood sugar control in patients with type 2 diabetes.
How to take
Adult dose
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg.
⦁ For patients taking this medicine whose blood glucose is not adequately controlled with metformin alone or in combination with other drugs such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose).
⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin.
When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions).
This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin.
If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose.
Special populations
Patients with renal impairment
No dosage adjustment is necessary in patients with mild renal impairment.
Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other symptoms that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, given as 500 mg twice daily.
Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1).
If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Patients in Whom This Medicine Is Contraindicated, item 2).
Elderly patients
In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
Precautions
This medication can cause a rare but very serious side effect known as severe lactic acidosis, so patients at high risk for lactic acidosis should use caution. During treatment, hypoglycemia may occur if used with other diabetes medications such as insulin or sulfonylureas, thus blood sugar levels should be monitored carefully. Patients with moderate to severe renal impairment, acute kidney problems, severe infections, or cardiovascular issues should not use this medication. If undergoing surgery or tests using iodinated contrast, this medication should be discontinued for a period, and renal function should be verified as normal before resuming. This medication may cause fluid loss, so special caution is necessary for patients with dehydration symptoms or at risk for decreased fluid volume. Women who are pregnant or may become pregnant, and nursing mothers should not use this medication; especially during pregnancy, insulin therapy is recommended. Regular monitoring of liver or kidney function tests is advised during treatment to check for abnormalities. If symptoms such as fever, pain, redness, swelling in the genital or perineal area occur, immediate medical attention should be sought. This medication may reduce vitamin B12 levels, so patients on long-term treatment should periodically check their vitamin B12 levels. Alcohol can increase the risk of side effects from this medication, so excessive drinking should be avoided during treatment. Elderly patients, particularly those aged 75 and older, are at higher risk for fluid loss and should take caution, possibly requiring dose adjustments based on renal function. In the event of an overdose, immediate medical treatment is required, and if lactic acidosis is suspected, blood dialysis may be necessary. Finally, this medication should be kept out of the reach of children and safely stored in the original container.
Side effects
Hypoglycemia
urinary tract infection
genital infection
increased urination
nausea
vomiting
diarrhea
abdominal pain
loss of appetite
constipation
Show 228 moreCollapse
abnormal liver function tests
hepatitis
altered taste
pruritus
rash
urticaria
erythema
angioedema
dysuria
interstitial nephritis
thirst
increased serum lipids
increased serum creatinine
decreased glomerular filtration rate
vulvovaginitis
vulvar vaginitis
glans inflammation
perineal necrosis
decreased fluid volume
hypotension
decreased systolic blood pressure
dehydration
low blood pressure
reduced blood volume
orthostatic hypotension
syncope
decreased and deficient vitamin B12
ketoacidosis
lactic acidosis
headache
dizziness
cerebral infarction
soft tissue infection
pneumonia
ankle fracture
epicondylitis
facial bone fracture
musculoskeletal pain
myocardial infarction
diarrhea
nausea
gastric ulcer
colitis
ischemic colitis
colonic hemorrhage
appendiceal abscess
appendicitis
meningitis
chronic otitis media
peritonsillar abscess
pulmonary tuberculosis
sepsis
subcutaneous abscess
uterine-ovarian abscess
vestibular neuritis
acute pyelonephritis
headache
positional dizziness
drowsiness
weakness
chest discomfort
chest pain
fever
chills
strange feeling
edema
pain
vascular stent stenosis
vascular stent thrombosis
increased alanine aminotransferase
increased aspartate aminotransferase
weight loss
vulvar pruritus
benign prostatic hyperplasia
diabetic retinopathy
diplopia
epistaxis
asthma
exertional dyspnea
wet cough
allergic rhinitis
cough
skin laceration
contusion
rib fracture
concussion
corneal abrasion
falls
hand fracture
iliolumbar ligament syndrome
open globe injury
pelvic fracture
road traffic accident
splenic injury
sternum fracture
angina pectoris
palpitations
Prinzmetal angina
coronary artery disease
tachycardia
atherosclerosis
deep vein thrombosis
diabetic vascular complications
peripheral arterial occlusive disease
anxiety
depression
sleep disorders
otalgia
positional vertigo
dizziness
anemia
lymphadenopathy
hypothyroidism
thyroid mass
constipation
dyspepsia
gastritis
gastrointestinal disorders
herpes zoster
cervical inflammation
erectile dysfunction
atrophic vaginitis
cervical dysplasia
vaginal discharge
hypoglycemia
decreased appetite
obesity
thirst
hyperlipidemia
dermoid cyst
seborrheic dermatitis
atopic dermatitis
diabetic foot
nummular eczema
heat rash
sebaceous gland hyperplasia
lumbar spinal canal stenosis
myalgia
limb pain
musculoskeletal chest pain
arthralgia
cervical stenosis
fibromyalgia
flank pain
fracture pain
muscle weakness
osteoarthritis
osteoporosis
rotator cuff syndrome
astigmatism
cataract
allergic conjunctivitis
blurred vision
corneal erosion
macular fibrosis
ocular discomfort
ocular congestion
pathologic myopia
retinal detachment
retinal crystals
retinal vein occlusion
traction retinal detachment
eyelid swelling
visual impairment
vitreous floaters
vitreous hemorrhage
nasopharyngitis
upper respiratory infection
periodontitis
tooth abscess
positional dizziness
sensory loss
perceptual abnormality
amnesia
carotid stenosis
diabetic neuropathy
facial paralysis
intracranial aneurysm
memory impairment
neuralgia
Parkinsonism
polyneuropathy
sensory disorders
drowsiness
CNS-origin dizziness
fatigue
peripheral edema
facial edema
peripheral swelling
facial swelling
chills
strange feeling
edema
pain at the puncture site
vascular stent stenosis
vascular stent thrombosis
chest pain
fatigue
peripheral swelling
facial swelling
edema
weight gain
electrocardiogram abnormalities
decreased hemoglobin
increased hemoglobin
positive Helicobacter test
positive urine for red blood cells
ureteral calculi
acute kidney injury
chronic kidney disease
hematuria
hypertonic bladder
kidney mass
urinary retention
urinary pain
abnormal urination
benign prostatic hyperplasia
erectile dysfunction
atrophic vaginitis
cervical inflammation
scrotal pain
sexual dysfunction
vaginal discharge
hyperglycemia
diabetes mellitus
hyponatremia
dyslipidemia
unstable angina
Not everyone experiences these, and they can vary from person to person.
Storage
This medication should be stored in a tightly sealed container to protect it from air and moisture. A storage temperature between 1 and 30 degrees Celsius at room temperature is recommended. Proper storage helps maintain the medication's effectiveness over time.
Appearance and packaging
Appearance
White, oval-shaped, double-sided convex film-coated tablet with a pink tint
Package unit
60 tablets/box [(10 tablets/PTP x 6)], 10 tablets/box [(10 tablets/PTP x 1)], 30 tablets/bottle, 60 tablets/bottle
Same-ingredient medicines
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety. Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.